Biogen (1BIIB) Financial Statements
Biogen Financial Overview
Biogen's market cap is currently $33.57B. The company's EPS TTM is $2.36; its P/E ratio is 107.47; Biogen is estimated to report earnings on February 17, 2027, and the estimated EPS forecast is $2.56. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.81B | $ 9.68B | $ 9.84B | $ 10.17B | $ 10.98B |
| Gross Profit | $ 6.91B | $ 7.37B | $ 7.30B | $ 7.90B | $ 8.87B |
| Operating Income | $ 1.88B | $ 2.49B | $ 2.10B | $ 2.89B | $ 2.79B |
| EBITDA | $ 2.95B | $ 3.00B | $ 2.38B | $ 3.54B | $ 3.92B |
| Net Income | $ 1.29B | $ 1.63B | $ 1.16B | $ 3.05B | $ 1.56B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.82B | $ 2.38B | $ 1.05B | $ 4.89B | $ 3.80B |
| Total Assets | $ 29.44B | $ 28.05B | $ 26.84B | $ 24.55B | $ 23.88B |
| Total Debt | $ 6.95B | $ 6.63B | $ 7.34B | $ 6.61B | $ 7.60B |
| Net Debt | $ 3.94B | $ 4.26B | $ 6.29B | $ 3.19B | $ 5.34B |
| Total Liabilities | $ 11.18B | $ 11.33B | $ 12.05B | $ 11.17B | $ 12.92B |
| Stockholders' Equity | $ 18.26B | $ 16.72B | $ 14.80B | $ 13.40B | $ 10.90B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.05B | $ 2.52B | $ 1.24B | $ 1.14B | $ 3.38B |
| Operating Cash Flow | $ 2.20B | $ 2.88B | $ 1.55B | $ 1.38B | $ 3.64B |
| Investing Cash Flow | $ -1.37B | $ -799.20M | $ -4.09B | $ 1.59B | $ -563.70M |
| Financing Cash Flow | $ -301.90M | $ -683.50M | $ 137.00M | $ -1.76B | $ -2.09B |
Currency in USD
